pargyline has been researched along with Carcinoma, Anaplastic in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, M | 1 |
| Liu, X | 1 |
| Jiang, G | 1 |
| Chen, H | 1 |
| Guo, J | 1 |
| Weng, X | 1 |
1 other study available for pargyline and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Relationship between LSD1 expression and E-cadherin expression in prostate cancer.
Topics: Cadherins; Carcinoma; Cell Line, Tumor; Disease Progression; Histone Demethylases; Humans; Male; Neo | 2015 |